-
1 Comment
Chong Kun Dang Pharmaceutical Corp is currently in a long term downtrend where the price is trading 18.1% below its 200 day moving average.
From a valuation standpoint, the stock is 86.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.
Chong Kun Dang Pharmaceutical Corp's total revenue rose by 13.1% to $337B since the same quarter in the previous year.
Its net income has dropped by 29.5% to $11B since the same quarter in the previous year.
Finally, its free cash flow grew by 66.8% to $17B since the same quarter in the previous year.
Based on the above factors, Chong Kun Dang Pharmaceutical Corp gets an overall score of 3/5.
Exchange | KO |
---|---|
CurrencyCode | KRW |
Industry | Drug Manufacturers - Specialty & Generic |
ISIN | KR7185750007 |
Sector | Healthcare |
Market Cap | 1T |
---|---|
Target Price | 124571.43 |
Dividend Yield | 1.3% |
Beta | 0.92 |
PE Ratio | None |
Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. It provides prescription drugs for anticancer, anti-hypertension, anti-hyperlipidemia, anti-diabetic, and immunosuppressant products; over-the-counter drugs for therapeutic benefits, supplements, and other preventive products; health supplements with preventive benefits, including prebiotics and vitamins with Omega-3; and consumer health products, such as red-ginseng healthy drink, hand sanitizer, and hair color medication, as well as insecticides. The company also exports its products. Chong Kun Dang Pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 185750.KO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025